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A B S T R A C T   
Background: Arsenic (As) is considered to be toxic for humans, the main routes of exposure being through 
drinking water and the diet. Once ingested, inorganic arsenic can be methylated sequentially to monomethyl and 
dimethyl arsenicals. Several factors can affect both As exposure and methylation efficiency. 
Objectives: To describe the urinary concentrations of the different As species and evaluate the methylation effi-
ciency during pregnancy, as well as their associated factors in a birth cohort of pregnant Spanish women. 
Methods: Participants in this cross-sectional study were 1017 pregnant women from two areas of Spain who had 
taken part in the INMA (Environment and Childhood) project (2003–2008). Total As (organic and inorganic 
compounds) and its main metabolites (monomethylarsonic acid, [MMA], dimethylarsinic acid, [DMA], inorganic 
As [iAs]) and arsenobetaine [AB]) were measured in urine samples collected during the first trimester. Socio-
demographic and dietary information was collected through questionnaires. Multivariate linear regression 
models were used to explore the association between As species concentrations and covariates. Arsenic 
methylation efficiency was determined through the percentages of the metabolites and using As methylation 
phenotypes, obtained from principal component analysis. 
Results: Median urine concentrations were 33.0, 21.6, 6.5, 0.35 and 0.33 μg/g creatinine for total As, AB, DMA, 
MMA and iAs, respectively. Daily consumption of rice and seafood during the first trimester of pregnancy were 
positively associated with the concentration of As species (i.e., β [CI95%] = 0.36 [0.09, 0.64] for rice and iAs, 
and 1.06 [0.68, 1.44] for seafood and AB). TAs, AB and iAs concentrations, and DMA and MMA concentrations 
were associated with legume and vegetable consumption, respectively. The medians of the percentage of As 
metabolites were 89.7 for %DMA, 5.1 for %MMA and 4.7 for %iAs. Non-smoker women and those with higher 
body mass index presented a higher methylation efficiency (denoted by a higher %DMA and lower %MMA). 
Abbreviations: AB, Arsenobetaine; As, arsenic; AS3MT, Arsenic [+3 oxidation state] methyltransferase gene; BMI, body Mass Index; Cd, cadmium; CI, confident 
intervals; DMA, dimethylarsinic acid; EFSA, European Food Safety Authority; FFQ, food frequency questionnaire; GM, geometric mean; GSH, glutathione; HPLC, 
high-performance liquid chromatography; iAs, inorganic arsenic; ICP-MS, inductively coupled plasma mass spectrometry; INMA, INfancia y Medio Ambiente 
(Environment and Childhood); LOD, limit of detection; MMA, monomethylarsonic acid; Mn, manganese; oAs, organic Arsenic; OCM, one-carbon metabolism; PCA, 
principal component analysis; SAM, S-adenosylmethionine; SD, standard deviation; Se, selenium; TAs, total arsenic; ΣAs, sum of iAs DMA and MMA; w.w., wet 
weight; WHO, World Health Organization; Zn, zinc. 
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Discussion: Certain dietary, lifestyle, and environmental factors were observed to have an influence on both As 
species concentrations and methylation efficiency in our population. Further birth cohort studies in low exposure 
areas are necessary to improve knowledge about arsenic exposure, especially to inorganic forms, and its potential 
health impact during childhood.   
1. Introduction 
Arsenic (As) is a toxicant that appears naturally in the soil; however, 
several human activities also contribute to the presence of As in the 
environment (European Food Safety Authority, 2009; Fowler et al., 
2015). Arsenic can be classified into two groups: organic and inorganic 
compounds, the inorganic forms being the more toxic species. In some 
areas of Bangladesh, India, Vietnam, China, Argentina, Chile, Mexico, 
Australia and USA, the levels of As in drinking water are above the 
maximum guideline value recommended by the World Health Organi-
zation (WHO) in 2003 (10 μg/L) (World Health Organization, 2017), 
water consumption being the main exposure route for iAs. In regions 
with low levels of As in water, such as Spain, the main source of exposure 
to inorganic As (iAs) is rice consumption (European Food Safety Au-
thority, 2014). Regarding organic As (oAs), the main contributor is the 
consumption of seafood. Arsenobetaine (AB) is usually the major form of 
arsenic in fish and other seafood. This compound and other oAs forms, 
such as arsenosugars and arsenolipids, are generally considered less 
toxic than iAs, although in vitro studies revealed cytotoxic effects of 
certain arsenic-containing hydrocarbons (Bornhorst et al., 2020). 
Arsenic absorbed by the gastrointestinal tract is biotransfomed 
mainly in the liver (Drobná et al., 2010). Currently, the biotransfor-
mation mechanism is not entirely clear, and several possible pathways 
have been described (Cullen, 2014). The classic pathway proposed by 
Challenger (1945) was based on the enzymatic reduction and oxidative 
methylation of As. In this scheme, ingested iAs is reduced (from arsenate 
-iAsV- to arsenite -iAsIII-) and methylated to monomethylarsonic acid 
(MMA) and dimethylarsinic acid (DMA), S-adenosylmethionine (SAM) 
being the main donor of the methyl group (Cullen, 2014; Howe et al., 
2014). After this biotransformation process, iAs is excreted through the 
urinary system. In general, the most frequent proportions of the me-
tabolites observed in urine are 60–80% of DMA, 10–20% of MMA and 
10–30% of iAs (Vahter, 1999). These relative concentrations reflect the 
iAs methylation efficiency, indicated by a high %DMA and lower %MMA 
and %iAs, especially in populations exposed to high levels of iAs through 
drinking water (Vahter, 1999). This methylation process is considered to 
be a detoxification mechanism, although high reactivity and toxicity of 
intermediate compounds, such as MMA, has been demonstrated (Vahter, 
2002). Several factors can influence the methylation efficiency, such as 
age, sex, alcohol and tobacco consumption (Shen et al., 2016; Tseng, 
2008). Some nutritional factors seem to increase the efficiency of iAs 
methylation, especially micronutrients involved in one-carbon meta-
bolism (OCM), such as vitamins B6 and B12, betaine, choline and folic 
acid (Bozack et al., 2019; Gamble et al., 2006; Heck et al., 2007; Howe 
et al., 2017a; Kurzius-Spencer et al., 2017; Laine et al., 2018; Spratlen 
et al., 2017). Likewise, other experimental and epidemiological studies 
have shown that some elements, such as selenium (Se), manganese 
(Mn), zinc (Zn), or cadmium (Cd) can have an influence on As meta-
bolism or interact with this metalloid (Nordberg et al., 2005; Rahman 
et al., 2019; Sun et al., 2014; Valeri et al., 2016). Regarding organic 
forms, AB is excreted unchanged in urine, but other organic forms, such 
as the arsenosugar and arsenolipid species present in seafood, seem to be 
metabolized and produce DMA (European Food Safety Authority, 2009; 
Molin et al., 2012; Taylor et al., 2017a). 
The effects of As exposure have been studied extensively. In 2009, As 
and iAs compounds were classified as carcinogenic to humans (Inter-
national Agency for Research on Cancer, 2012). Other health effects 
described in adults have been an increased risk of respiratory, cardio-
vascular, and metabolic diseases (Agency for Toxic Substances and 
Disease Registry, 2016; Moon et al., 2012; Sanchez et al., 2016). 
Furthermore, a lower As methylation efficiency has been related to a 
higher risk of skin lesions, bladder, lung and skin cancer, and peripheral 
vascular disease (Gamboa-loira et al., 2017; Tseng, 2007). The fetus 
could be exposed to this toxicant due to transfer of maternal As across 
the placenta (Gossai et al., 2015). Methylation efficiency has been 
observed to be augmented during pregnancy, thus increasing the 
excretion of DMA (Hopenhayn et al., 2003). Nevertheless, several 
studies have identified adverse effects on fetal and child development 
caused by prenatal exposure to As, such as miscarriage, low birth 
weight, skin lesions, respiratory effects, and impairment of neuropsy-
chological development (Freire et al., 2018; Hamadani et al., 2011; 
Parajuli et al., 2013; Quansah et al., 2015; Sanchez et al., 2016). 
Therefore, the aim of this study is to describe the concentrations of 
total As (TAs) and the different urinary As species (DMA, MMA, AB and 
iAs) and the methylation efficiency in a birth cohort of pregnant Spanish 
women. Additionally, we have studied the factors (nutritional, socio-
demographic and lifestyle variables) associated with both As exposure 
and methylation efficiency. 
2. Materials and methods 
2.1. Study population 
In this cross-sectional study, subjects were pregnant women 
participating in the INMA (Environment and Childhood) Project, a 
multicentre birth cohort study that aims to investigate the effect of 
environmental exposures and diet during pregnancy and childhood on 
fetal and child development in different geographical areas of Spain (htt 
p://www.proyectoinma.org). 
The study protocol has been reported elsewhere (Guxens et al., 
2012). Briefly, 1465 pregnant women were recruited during their first 
antenatal visit (2003–2008) in two regions of Spain: Gipuzkoa (north of 
Spain, n=638) and Valencia (east of Spain, n=855). The inclusion 
criteria were: at least 16 years of age, 10–13 weeks of gestation, 
singleton pregnancy, intention of undergoing follow-up and delivery in 
the corresponding centre of reference, and no impediment for commu-
nication. These women were monitored during pregnancy. The final 
study population was made up of 1017 mothers with available urinary 
arsenic species concentrations at the first trimester of pregnancy (69.4% 
of total recruited participants). These mothers were selected taking into 
account two criteria: 1) availability of longitudinal information about 
their children until 2 years old (in order to assess the potential health 
effects of prenatal As exposure in further studies), and 2) from the 
women who met the first criterion we randomly selected a subsample of 
1017 due to limited funding for the As analysis. 
The study protocol was approved by the Ethics Committee of the 
university hospital La Fe (Valencia), the Ethics Committee of the Public 
Health Research Centre in Valencia (CSISP) and the Ethics Committee of 
Donostia Hospital (Gipuzkoa). Informed consent was obtained from all 
participants in each phase. 
2.2. Study variables and sources of information 
2.2.1. Outcome variable: urinary arsenic speciation analysis 
Concentrations of total As and its metabolites were determined in 
spot urine samples collected in the first trimester of pregnancy (mean 
[SD]= 13.0 [1.2] weeks of gestation). Urine samples were kept frozen at 
− 80 ◦C until analysis. 
R. Soler-Blasco et al.                                                                                                                                                                                                                           
Environmental Research 196 (2021) 110889
3
The total As concentrations were determined with an inductively 
coupled plasma tandem mass spectrometer (ICPMS/MS, 8800, Agilent 
Technologies, Waldbronn, Germany) with oxygen as the reaction gas at 
m/z 75 → 91. An external calibration was used for quantification, from 
0.05 to 100 μg As/L. The certified reference materials (CRM) SRM 1640a 
(Trace elements in natural water, NIST, Gaithersburg, USA, n=12) and 
SRM 2669 I and II (Arsenic Species in Frozen Human Urine, n=14) were 
used for quality control. A calibration standard was re-measured after 
every 10th sample to monitor the stability of the measurement. 
Chromatographic separation of the arsenic compounds was carried 
out in accordance with a previously validated method (Scheer et al., 
2012). An external calibration was used for quantification. It contained 
arsenate, MMA, DMA and AB in the concentration range 0.05–100 μg 
As/L. Hydrogen peroxide (10% v/v) was added to oxidize the species. 
For quality control, the CRMs SRM 1640a (n= 5), SRM 2669 I (n = 8) 
and SRM 2669 II (n = 22) were prepared similar to the urine samples 
and also investigated. The 1.0 μg As/L calibration standard was injected 
regularly to control the stability of the measurement. Every 10th sample 
was also re-measured for the same purpose. Of all the samples analysed 
(1017), 102 were re-analysed, which represents 10%. These second 
measurements matched the first in 100 ± 3% of the cases. 
HPLC (1200, Agilent Technologies) coupled to ICPMS/MS (8800, 
Agilent Technologies) was employed for speciation analysis. The arsenic 
signal was again recorded in oxygen reaction mode at m/z 75 → 91, with 
the addition of CO2 for signal enhancement. 
TAs concentrations and the sum of all As species were compared. 
When the difference was larger than 15%, either the total arsenic or the 
speciation analysis was repeated (124 samples). 
Limits of detection (LOD) of AB, DMA, MMA and iAs for the samples 
from Valencia were 0.02, 0.02, 0.03 and 0.03 μg/L and for the Gipuzkoa 
samples they were 0.02, 0.03, 0.03 and 0.02 μg/L. When samples were 
below LOD, ½ LOD was assigned for the statistical analysis (2.8% of 
samples for MMA levels and 2.3% of samples for iAs levels). 
2.2.2. Covariates 
2.2.2.1. Sociodemographic variables. Women filled in two question-
naires during their pregnancy, at the first and the third trimesters of 
gestation (mean [SD]= 13.1 [1.5] and 32.5 [2.2] weeks of gestation, 
respectively). The questionnaires were administered by trained in-
terviewers and focused on sociodemographic, environmental and life-
style information. In both cohorts, the questionnaires were offered in 
Spanish and, additionally, in the co-official language (Basque) in the 
Gipuzkoa cohort. We selected the covariates used in this study from the 
previous literature on this topic (European Food Safety Authority, 2014; 
Nigra et al., 2019; Saxena et al., 2018; Shen et al., 2016; Tseng, 2008): 
age at conception (years), education level (up to primary, secondary, 
university), place of birth (Spain, Latin America, other), body mass 
index (BMI, kg/m2) before pregnancy (continuous and categorized by 
low and healthy weight [<25], overweight [25 ≤ 30], obesity [≥30]), 
parity (0, ≥1), working status at first trimester of pregnancy 
(non-worker, worker), area of residence (rural, non-rural), tobacco and 
alcohol consumption in the first trimester of pregnancy (yes, no), and 
season of sample collection (spring, summer, winter, autumn). Subjec-
tive variables about the proximity of the residence to industrial or 
agricultural areas (yes, no) and frequency of traffic near the residence 
(continuous, quite frequent, infrequent/never) were collected. 
We defined parental social class from the maternal or paternal 
occupation during pregnancy with the highest social class, according to 
the Spanish adaptation of the International Standard Classification of 
Occupations coding system approved in 1988 (ISCO88). Class I + II 
included managerial jobs, senior technical staff, and commercial man-
agers; Class III included skilled non-manual workers; and class IV + V 
included manual and unskilled workers. 
2.2.2.2. Dietary variables. Information on diet during the first trimester 
of pregnancy was obtained from a 100-item semi-quantitative food 
frequency questionnaire (FFQ) completed at the time of sampling. The 
dietary information covered the time from the last menstruation to the 
first prenatal visit, which occurred between weeks 10 and 13 of preg-
nancy. This FFQ was validated with good reproducibility for nutrient 
and food intake (Vioque et al., 2013). The items had nine possible re-
sponses, ranging from ‘never or less than once per month’ to ‘six or more 
per day’. A commonly used serving size was specified for each food item 
in the FFQ. This was converted to average daily intake in grams for each 
individual participant. We obtained data on the intake of dairy products, 
eggs, meat, seafood and shellfish, fruits, vegetables, legumes, nuts, po-
tatoes, cereals and bread, and coffee and other infusions. Some foods 
were explored in a more comprehensive manner due to their clear 
relationship with As concentrations, as is the case of rice, other cereals 
and bread, fish split into categories (lean fish, oily fish and shellfish and 
molluscs), and meat split into categories (red and white meat) (Euro-
pean Food Safety Authority, 2009). Moreover, we obtained information 
about consumption of tap water (less than 1 glass [250 cc] a day, 1 or 
more glasses a day). 
Additionally, dietary folate, folic acid, vitamins B12 and B6, iron (Fe) 
and Zn intake were estimated using the food composition tables of the 
US Department of Agriculture (U.S. Department of Agriculture: Agri-
cultural Research Service USDA, 2007) and with Spanish sources (Palma 
et al., 2008). Energy-adjusted intakes were computed using the residual 
method (Willet, 2013). Information on the intake of supplements (brand 
name, dose and composition) was also collected, converted into nutrient 
intake daily dose, and added to the calculation of total daily nutrient 
intake (Vioque et al., 2013). Moreover, categorical variables were 
created for estimated vitamins B12 and B6, folate, Fe and Zn intake (<or 
≥ the Population Reference Intake for Fe, Zn and vitamin B6 and 
adequate intake for folate and vitamin B12) (European Food Safety Au-
thority, 2019). 
2.2.2.3. Other elements. Mn and Se concentrations were determined in 
serum samples taken at the first trimester of pregnancy. More infor-
mation about the methodology has been reported in detail elsewhere 
(Lozano et al., 2020; Soler-Blasco et al., 2020). Cd concentrations were 
determined by ICPMS in urine samples taken at the first trimester of 
pregnancy. Creatinine concentrations were measured in the same urine 
samples at the first trimester of pregnancy by DRI® Crea-
tinine-Detected® Test using AV680 from Beckman Coulter. The quan-
tification of maternal plasmatic levels of ferritin was performed by 
fluoroimmunoassay (DELFIA Ferritin kit A069-101), in the Gipuzkoa 
Public Health Laboratory. In Valencia, the quantification was performed 
at La Fe hospital through immunoturbidimetry in Beckman Coulter AU 
analysers (Arija et al., 2019). 
2.3. Statistical analysis 
Descriptive and bivariate analyses were performed using Fisher’s 
Exact Test for categorical variables and the Kruskall Wallis Test for 
continuous variables in order to detect any differences between the 
included and the excluded populations. 
In populations with moderate-high fish/seafood consumption, the 
ΣAs could not properly reflect the exposure to inorganic As, because oAs 
from seafood contributes to DMA levels and TAs (Navas-Acien et al., 
2011). To eliminate the influence of seafood arsenicals, we calibrated 
the methylated and non-methylated species concentrations using a 
mathematical method proposed by Jones et al. (2016). In brief, AB 
concentrations were used as a marker of seafood consumption. Using 
linear regression models, calibrated iAs, DMA and MMA concentrations 
were estimated by regressing the measured concentrations of iAs, MMA, 
and DMA on AB and creatinine concentrations (all measures were log-2 
transformed) in three separate models. The new calibrated iAs, MMA 
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and DMA concentrations were calculated by adding the residual of each 
metabolite model to a constant (mean level of each metabolite estimated 
from participants with AB<1 μg/L). 
We calculated the geometric mean (GM) and 95% confidence in-
tervals (95%CI) of the urinary TAs, AB, DMA, MMA, iAs, and ΣAs (as the 
sum of iAs, DMA and MMA]) for both measured and calibrated con-
centrations. Additionally, GM and 95%CI of the measured concentra-
tions were calculated according to sociodemographic, environmental 
and dietary characteristics of the study population. Concentrations were 
expressed in μg/L and corrected to creatinine content (μg/creatinine). 
The GMs were compared using the ANOVA F-test. For further analysis, 
we used the log2 and probit-transformed values of the urinary As species 
concentrations and the percentage of the individual metabolites, 
respectively, to approach normality. 
Bivariate and multivariate linear regression models were built in 
order to study the relationship between urinary As concentrations and 
the sociodemographic, environmental, and dietary factors. Beta co-
efficients (β) and 95%CI were obtained. A two-step procedure was used 
to construct the multivariate models. First, core models were built using 
all the sociodemographic and environmental covariates associated with 
a p value < 0.2 in the bivariate analysis. Following a backward elimi-
nation procedure, the covariates associated with each species at a level 
of p value < 0.1 in the likelihood ratio test were retained in the model. 
Second, each food group was adjusted in the core model individually. 
The final multivariate models were built using the core model and all the 
food groups associated with each species at a level of p value < 0.1 in the 
likelihood ratio test. Although food intake or estimated nutrients vari-
ables were mutually correlated (Fig. S1 and Fig. S2), we found no 
collinearity among them in the final models. The area of study (Valencia 
or Gipuzkoa) and urinary creatinine levels in the first trimester of 
pregnancy were included in all the models regardless of their statistical 
significance. 
Methylation As efficiency was determined through two approaches. 
First, by calculating the percentage of the individual calibrated metab-
olites (iAs, MMA and DMA) over the sum of those species (ΣAs). Second, 
a principal component analysis (PCA) of the three calibrated, untrans-
formed and un-rotated percentages was performed. The main reason for 
carrying out a PCA was to avoid the high correlation between the per-
centages of the three metabolites, by transforming the three interrelated 
variables into two independent measures of As metabolism phenotypes 
(Balakrishnan et al., 2016; Gribble et al., 2015; Jansen et al., 2016; 
Spratlen et al., 2017). The results obtained through the PCA analysis 
were two principal components (PC1 and PC2) that explained 100% of 
the original variance. Therefore, these PC were used as As methylation 
phenotypes. 
We analysed the factors associated with the methylation efficiency 
using the same procedure as described above. In particular, we per-
formed five different models by using the probit-transformed calibrated 
%DMA, %MMA, %iAs and untransformed PC1 and PC2 as outcome 
variables. In these models, the variables used in the second step were the 
estimation of nutrients and vitamin intake described above and Se, Mn 
and Cd concentrations. The area of study was also included. 
To check whether linear regression assumptions were met, we 
visually inspected model residuals for normality and homoscedasticity. 
No influential data were identified by Cook’s distance. Variance infla-
tion factors (VIFs) were used to test for collinearity among variables in 
the final models, all VIFs being <2.5. To deal with the possibility of 
minor deviations from normality and homoscedasticity, confidence in-
tervals were calculated on the basis of robust standard error in the final 
results. 
Statistical analyses were carried out using R statistical package 
version 3.5.1 (R Core Team, 2017). 
3. Results 
3.1. TAs and As metabolite concentrations and associated factors 
Differences between included and excluded subjects are shown in 
Table S1. Among the participants, there was a higher percentage of 
slightly older women with a higher level of education and higher social 
class than among the excluded women. There were no differences in rice 
consumption. Participants showed higher fish consumption than the 
excluded women. Among the participants, there was a slightly lower 
percentage of women who did not take any vitamin supplement during 
the period of the study (4% vs. 7%). 
The GM [95%CI] of measured urinary TAs, ΣAs and AB concentra-
tions were 35.55 [33.10–38.19], 7.74 [7.41–8.09] and 20.17 
[18.34–22.19] μg/g creatinine, respectively. Table 1 shows measured 
and calibrated As concentrations and the metabolite percentages. The 
calibrated concentrations of metabolites were lower in all cases, espe-
cially for DMA concentrations (GM [95%CI] 6.82 [6.52, 7.14] μg/g 
creatinine and 2.98 [2.85, 3.09] μg/g creatinine, in measured and 
calibrated DMA concentrations, respectively). Correlations between 
measured and calibrated metabolite concentrations were high (Pearson 
correlation coefficient of 0.85 for DMA, and 0.99 for MMA and iAs, p 
value < 0.01 in all cases). The correlation between DMA and TAs 
decreased from 0.69 to 0.23 when the metabolite was calibrated 
(Fig. S3). 
Table 1 
Geometric mean and 95% confidence intervals of measured and calibrateda urinary As concentrations and percentages. INMA Project (Valencia and Gipuzkoa, Spain. 
2003–2008).   
Measured concentrations Calibrated concentrationsa 
As concentrations μg/L μg/g creatinine μg/L μg/g creatinine  
TAs 28.89 (26.81, 31.13) 35.55 (33.10, 38.19)    
AB 16.40 (14.88, 18.08) 20.17 (18.34, 22.19)    
ΣAs 6.28 (5.98, 6.59) 7.74 (7.41, 8.09) 2.94 (2.82, 3.06) 3.62 (3.48, 3.76)  
DMA 5.54 (5.27, 5.82) 6.82 (6.52, 7.14) 2.41 (2.31, 2.51) 2.97 (2.85, 3.09)  
MMA 0.28 (0.26, 0.29) 0.34 (0.32, 0.36) 0.19 (0.18, 0.20) 0.23 (0.22, 0.24)  
iAs 0.27 (0.25, 0.29) 0.33 (0.31, 0.35) 0.21 (0.20, 0.23) 0.26 (0.25, 0.28) 
Metabolite percentages  
%DMAb 89.7 (89.3, 90.2)  84.4 (83.9, 84.9)   
%MMAb 5.1 (4.8, 5.3)  7.1 (6.7, 7.3)   
%iAsb 4.7 (4.5,5.0)  7.6 (7.3, 8.0)  
Note: TAs, Total As; ΣAs, sum of DMA, MMA and iAs; DMA, dimethylarsinic acid; MMA, monomethylarsonic acid; iAs, inorganic As; %DMA, percentage of dime-
thylarsinic acid; %MMA, percentage of monomethylarsonic acid; %iAs, percentage of inorganic As. 
The percentages of each metabolite were calculated: levels of the metabolite/(DMA + MMA + iAs)*100; μg/L: micrograms per litre. μg/g creat: micrograms per gram 
of creatinine. 
a As metabolite concentrations corrected by arsenobetaine concentrations; 
b Median (95% confidence intervals). 
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Table S2 shows the total As and metabolite concentrations by 
participant characteristics. Women from Gipuzkoa presented higher TAs 
and AB concentrations and lower levels of MMA and iAs than those from 
Valencia. Latin-American women presented higher concentrations of iAs 
and MMA than the Spaniards, and very low AB levels. The urine samples 
collected during spring presented higher levels of TAs, ΣAs, DMA, MMA 
and iAs. Consumption of more than 1 serving of rice per week was 
associated with an increase in DMA, MMA and iAs concentrations. 
Consumption of fish (<1 serving per week, 1 serving per week, > 1 
serving per week) showed a clearly increasing trend with AB and TAs 
concentrations. 
The multivariate models for the factors associated with the concen-
trations for each of the measured As species can be observed in Fig. 1. 
The area of study was significantly related to all As measures, except for 
ΣAs concentrations. Women from Valencia presented higher concen-
trations of MMA (β [95%CI]: 0.51 [0.35, 0.68], p value < 0.01) and iAs 
(β [95%CI]: 0.44 [0.23, 0.65], p value < 0.01), but lower concentrations 
of DMA (β [95%CI]: 0.17 [-0.31, − 0.02], p= 0.03) and AB (β [95%CI]: 
0.55 [-0.85, − 0.24, p value < 0.01). Latin-American mothers showed 
lower concentrations of AB and the TAs (β [95%CI]: 1.88 [-2.65, − 1.10], 
p value < 0.01, and − 0.74 [-1.22, − 0.26], p value =0.01, respectively). 
Parental social class was related to ΣAs and DMA concentrations, lower 
levels being observed in middle social class mothers (β [95%CI]: 0.23 
[-0.40, − 0.07], p value =0.01, and − 0.22 [-0.39, − 0.05], p value =0.01, 
respectively). Pre-pregnancy BMI was negatively associated with MMA 
and iAs concentrations (β [95%CI]: 0.03 [-0.04, − 0.01], p value < 0.01, 
and − 0.03 [-0.04, − 0.01], p =0.01, respectively). Proximity of resi-
dence to an agricultural area was positively and significantly related to 
MMA concentrations (β [95%CI]: 0.14 [0.001, 0.27], p value =0.05). 
Regarding dietary variables, a positive and significant association 
between seafood consumption and all As measures was observed, except 
for MMA and iAs concentrations, with a stronger association with AB 
concentrations (β [95%CI]: 1.06 [0.69, 1.43], p value < 0.01). 
Similarly, rice consumption during pregnancy was positively asso-
ciated with all As measures (β [95%CI]: 0.63 [0.27, 0.99], p value < 0.01 
for TAs; 0.64 [0.46, 0.86], p value < 0.01 for ΣAs; 0.70 [0.47, 0.92], p 
value < 0.01 for DMA; 0.50 [0.26, 0.73], p value < 0.01 for MMA; and 
0.36 [0.09, 0.64], p value =0.01 for iAs), except for AB concentrations. 
Consumption of other cereals was positively associated with iAs con-
centrations (β [95%CI]: 0.12 [-0.01, 0.25], p value =0.07). The associ-
ation between the intake of legumes and TAs and AB concentrations was 
negative (β [95%CI]: 0.48 [-0.90, − 0.05], p value =0.03; and − 0.62 
[-1.17, − 0.07], p value =0.03, respectively), but positive for iAs (β [95% 
Fig. 1. Beta coefficients (CI95%) of the multivariate linear regression between measured levels of arsenic metabolites in maternal urine, and sociodemographic and 
dietary factors. INMA Project (Valencia and Gipuzkoa, Spain, 2003–2008). Note: TAs, Total As; 
∑
As, sum of DMA, MMA and iAs; DMA, dimethylarsinic acid; MMA, 
monomethylarsonic acid; iAs, inorganic As; ref, category reference; Coll, collection: Prox.agric.area, proximity to agricultural area. Dietary factors are expressed in 
100 g per day at first trimester of pregnancy, adjusted for calories. Reference categories: area of study (Gipuzkoa); season of sample collection (winter); maternal 
country of birth (Spain); parental social class (high); proximity to agricultural area (no). Samples used in all models were n=1005, except for log2 MMA model 
(n=994). TAs, AB, 
∑
As, DMA, MMA and iAs concentrations were log2-transformed.*Age and pre-pregnancy BMI variables were expressed as increments of 5 years 
and 5 kg/m2, respectively. 
Table 2 
Summary of principal components analysis of calibrateda percentage As 
metabolites.   
PC1 PC2 
Standard deviation 0.13 0.05 
Proportion of variance 0.88 0.12 
Weight for calibrateda %DMA 0.77 0.27 
Weight for calibrateda %MMA − 0.15 − 0.80 
Weight for calibrateda %iAs − 0.62 0.53 
Note: PC1, principal component 1; PC2, principal component 2; %DMA, per-
centage of dimethylarsinic acid; %MMA, percentage of monomethylarsonic 
acid; %iAs, percentage of inorganic As. 
a As metabolite concentrations corrected for arsenobetaine and creatinine 
concentrations. 




Beta coefficient (95%CI) of the multivariate linear regression between methylation efficiency (measured by calibrated1 percentage of As metabolites in maternal urine and principal component 1 and 2 of PCA) and 
sociodemographic, estimated nutrients intake (adjusted for calories) and essential and toxics elements factors. INMA Project (Valencia and Gipuzkoa, Spain, 2003–2008).   
Calibrated %DMAa,b (n= 1005) Calibrated %MMAa,b (n= 998) Calibrated %iAsa,b (n= 999) PC1 (n= 992) PC2 (n= 992)  
Beta (95%CI) Pc Beta (95%CI) Pc Beta (95%CI) Pc Beta (95%CI) Pc Beta (95%CI) Pc 
Sociodemographic, environmental and lifestyle variables 
Area of study (ref. Gipuzkoa)  
Valencia − 8.90 (− 13.95, − 3.85) <0.01 12.41 (7.22, 17.60) <0.01 6.55 (0.73, 12.37) 0.02 − 0.02 (− 0.04, 0.00) 0.03 − 0.02 (− 0.02, − 0.01) <0.01 
Place of birth (ref. Spain)  
Latin America 14.24 (1.50, 26.97) 0.03 − 18.28 (− 26.98, − 9.59) <0.01     0.03 (0.01, 0.04) <0.01  
Other − 3.87 (− 18.13, 11.19)  0.55 (− 9.78, 10.88)      0.01 (− 0.01, 0.02)  
Working status (ref. non-worker)  
Worker   − 4.84 (− 9.34, − 0.34) 0.05     0.01 (0.01, 0.02) 0.03 
Parental social class (ref. I + II high)  
III       0.002 (− 0.020, 0.025) 0.08    
IV + V (low)       0.020 (− 0.001, 0.040)    
Tobacco consumption (ref. no)  
Yes     6.07 (− 0.07, 12.20) 0.08 − 0.022 (− 0.042, − 0.002) 0.03   
Body mass index 1.16 (0.60, 1.72) <0.01 − 0.83 (− 1.31, − 0.35) <0.01 − 0.94 (− 1.52, − 0.36) <0.01 0.003 (0.002, 0.005) <0.01 0.001 (0.000, 0.001) 0.02 
Gestational age at sampling   − 1.95 (− 4.24, 0.35) 0.05       
Estimated daily intake of nutrients 
Estimated maternal zinc  
intake (mg/day)d,e 
7.71 (− 1.31, 16.81) 0.09         
Estimated maternal iron  
intake (mg/day)d,e     
− 0.016 (− 0.036, 0.004) 0.02   
Estimated maternal folate  
ntake (μg/day)d         
0.002 (0.000, 0.004) 0.01 
Other toxic elements 
Maternal urine cadmium (μg/L)e   1.89 (0.29, 3.49) 0.02     − 0.002 (− 0.005, − 0.00) 0.03 
Note: 95%CI, 95% confidence intervals; %DMA, percentage of dimethylarsinic acid; %MMA, percentage of monomethylarsonic acid; %iAs, percentage of inorganic As. PCA, principal component analysis; PC1, principal 
component 1; PC2, principal component 2. 
The percentages of each metabolite were calculated: levels of calibrated metabolite/(calibrated DMA + calibrated MMA + calibrated unmethylated iAs. 
a Calibrated percentages were calculated with As metabolite concentrations corrected by arsenobetaine and creatinine concentrations; 
b Probit-transformed appears 
c p value from ANOVA F- test. 
d Estimated daily intake of nutrients from the diet and supplementation. 
e log2-transformed.Each model was simultaneously adjusted by all the presented variables. 




Geometric mean urinary arsenic concentrations and their metabolites measured in pregnant women in other published studies.  
Study Location Gestational Age N Year of 
sampling 
ΣAs iAs MMA DMA AB %iAs %MMA %DMA 
Present study Spain (GIP- 
VAL) 
1st trimester (13 
weeks) 




6.8 (6.5, 7.1)c 20.17 (18.34, 
22.19)c 














Gao (2019) Bangladesh 4–16 weeks 1425 2008–2011 ND 6.5 (0, 98.9)c,i 3.8 (0, 
57.9)c,i 




Howe (2020) US Early pregnancy 
(6–24 weeks) 
















Stajnko (2019) Croatia- 
Slovenia 



















2.57 (2.49, 2.65)b ND ND ND ND 










































ND ND ND ND 
Gilbert-Diamond 
(2011) 










ND ND ND 
Gardner (2011) Bangladesh 8 weeks 324 2001–2003 94 (3.0)b,d ND ND ND ND 16 ± 10e 11 ± 4.2e 73 ± 11e 
14 weeks   112.0 (3.0)b,d ND ND ND ND 14 ± 6.4e 7.6 ± 3.1e 79 ± 7.5e 
30 weeks   103 (2.9)b,d ND ND ND ND 10 ± 4.9e 6.5 ± 2.8e 83 ± 6.0e 
Jay Christian (2006) 
. 
Chile During pregnancy 
(not specified) 
93 1998–2000 55.8 (41.6)a,g 5.6 (5.5)a,g 3.2 (4.0)a,g 46.9 (36.1)a,g ND 11.0 (9.7)a,g 5.2 (4.7)a,g 83.8 
(11.0)a,g 
Note: ND, No data available; LOD, limit of detection; TiAs, Total inorganic iAs (sum of DMA, MMA and iAs); DMA, dimethylarsinic acid; MMA, monomethylarsonic acid; iAs, unmethylated inorganic As. 
a μg/L (unadjusted). 
b adjusted by specific gravity. 
c adjusted by creatinine (μg/g creatinine). 
d geometric standard deviation. 
e AM ± standard deviation. 
f Median (percentile 25, percentile 75). 
g Median (range). 
h Median (CI95%). 
i Median (percentile 5, percentile 95). 
j Pregnant women exposed to average iAs water concentration <0.5 μg/l. 
k Pregnant women exposed to average iAs water concentration 10.24 μg/l 
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CI]: 0.38 [0.06, 0.71]). Meat consumption was negatively associated 
with MMA concentrations (β [95%CI]: 0.26 [-0.43, − 0.09], p value 
=0.02). When seafood consumption was replaced by the different fish 
categories (lean fish, oily fish, and shellfish and mollusc consumption), a 
positive and significant association among the consumption of shellfish 
and molluscs and TAs, AB, ΣAs, DMA and iAs concentrations was 
observed (see Fig. S4). Similarly, the meat intake variable was split into 
two different categories (red and white meat), and only red meat was 
associated with the MMA metabolite (β [95%CI]: 0.39 [-0.61, − 0.18], p 
value < 0.01) (see Fig. S4). 
3.2. Arsenic methylation efficiency and factors associated 
The medians (95%CI) of the percentage of As metabolites were 89.7 
(89.3, 90.2) for %DMA, 5.1 (4.8, 5.3) for %MMA, and 4.7 (4.5, 5.0) for 
%iAs. When the percentage of As metabolites was calculated with the 
calibrated concentration, we observed a decrease in %DMA (84.4 [83.9, 
84.9]) and an increase in %MMA and %iAs (7.1 [6.7, 7.3] and 7.6 [7.3, 
8.0], respectively) (see Table 1). The variability of these three variables 
can be summarized by two principal components (Table 2). Principal 
component 1 (PC1) explained 88% of the variance and reflected higher 
%DMA, and lower %MMA and %iAs. Principal component 2 (PC2) 
explained the remaining 12% of the variance and reflected higher %iAs 
and lower %MMA. 
The variables associated with the percentage of each calibrated 
metabolite in the multivariate model can be observed in Table 3. The 
area of Valencia was associated with a lower methylation (higher % 
MMA and %iAs and lower %DMA). Latin-American mothers presented 
higher %DMA and lower %MMA (β [95%CI]: 14.2 [1.5, 26.3 and − 18.5 
[-27.3, − 9.8], respectively]), but this factor did not remain in the %iAs 
model. Mothers who worked during pregnancy showed lower %MMA. 
Tobacco consumption during the first trimester of pregnancy was asso-
ciated with higher %iAs (β [95%CI]: 6.1 [-0.07, 12.2]). Pre-pregnancy 
BMI was associated with a higher methylation (lower %MMA and % 
iAs and higher %DMA). Furthermore, gestational age at sampling was 
inversely related to %MMA (β [95%CI]: 0.84 [-1.32, − 0.36]). Regarding 
the estimated nutrients, only the estimation of daily intake of Zn was 
positively associated with %DMA in the bivariate analysis (Table S3), 
and this association continued to be present in the multivariate model, 
although in a marginal way (β [95%CI]: 7.71 [-1.39, 16.81]). The 
micronutrients involved in the one-carbon metabolism evaluated (esti-
mated folate and vitamins B6 and B12 intake) and other elements eval-
uated (serum Se and Mn concentrations) were not related to As 
metabolite percentages in the bivariate or the multivariate analyses 
(Table S3). Higher levels of urinary Cd were associated with higher % 
MMA (β [95%CI]: 1.89 [0.28, 3.49]). 
Finally, the variables associated with the As PC1 and PC2 methyl-
ation phenotypes in the multivariate model can be observed in Table 3. 
Regarding PC1, the area of Valencia, tobacco consumption during 
pregnancy and a higher estimated Fe intake were negatively associated 
with PC1. Pre-pregnancy BMI was directly associated with PC1, 
reflecting a better capacity to produce DMA. The factors associated with 
PC2 were the area of study (lower among the Valencian women), the 
place of birth (higher in Latin-American women), working situation 
during pregnancy (higher among workers) and higher BMI. 
4. Discussion 
In the present study, we measured the urinary concentrations of As 
metabolites in a large sample of pregnant women from Spain, a country 
without high levels of environmental iAs exposure, and high rice and 
seafood consumption. The main factor contributing to the As concen-
trations was diet, rice being the main source of exposure to inorganic 
species (iAs, MMA and DMA) while seafood contributed mainly to DMA 
and the organic form (AB). We also estimated the methylation efficiency 
by two different approaches (the relative percentages of each As 
metabolite and a principal component analysis). The factors that were 
most clearly associated were area of study, women’s place of origin, 
body mass index and tobacco consumption. When the percentages of 
calibrated iAs, MMA and DMA were combined into principal compo-
nents, 88% of the variance was explained by the first of them. 
4.1. Concentrations of As and its metabolites during pregnancy: 
comparison with previous studies 
Concentrations of urinary inorganic As species in our study popula-
tion were lower than those observed in other areas. For example, in 
Bangladesh or Chile the mean ΣAs concentrations [SD] were 112.0 [3.0] 
and 55.8 [41.6] μg/L (Gardner et al., 2011; Jay Christian et al., 2006), 
compared with the GM of 7.7 μg/g creatinine observed in the present 
study (Table 4). Other populations with higher levels of ΣAs are those 
from Mexico and China, with median concentrations of 23.3 μg/L and 
22.6 μg/g creatinine, respectively (Chou et al., 2014; Laine et al., 2015). 
These areas present high levels of As in groundwater, due to geochem-
ical natural processes, and also anthropogenic processes, such as mining 
or smelting (Litter et al., 2020). In our study, urinary concentrations of 
iAs and MMA were higher than in other studies carried out on regions 
with low levels of iAs in drinking water, such as some areas of USA, 
Croatia, Slovenia and Canada (Howe et al., 2020; Stajnko et al., 2019; 
Vaughan Watson et al., 2020). Conversely, in our study urinary AB 
concentrations were higher than in other studies conducted in USA, the 
main reason probably being the high fish and seafood consumption of 
the Spanish population. 
4.2. Factors associated with As exposure: dietary factors 
In our study, rice consumption was the main predictor of TAs and all 
As species, except for AB. A recent study conducted in Valencia (Spain) 
showed that rice was a foodstuff with high total As and iAs content (0.15 
and 0.06 mg/kg, respectively) (Marín et al., 2018). In that study, all the 
samples were below the limits established by the European regulation 
(0.20–0.25 mg/kg for iAs) (European Commission, 2015). In another 
study carried out on the Iberian Peninsula (Spain and Portugal), the As 
species concentrations were analysed according to the type of rice and 
geographical region (Signes-Pastor et al., 2016). The results showed that 
26% of the rice samples exceeded the levels of iAs established for 
rice-based food for infants and young children (0.10 mg/kg). The same 
study found that commercial brown rice was the type that presented the 
highest levels of iAs and DMA species (0.16 and 0.084 mg/kg, respec-
tively), compared with polished rice, both produced in the Iberian 
Peninsula region. Spain is the European country with the second highest 
consumption of rice, after Portugal (11 kg per capita per year) (Food and 
Agriculture Organization of the United Nations, 2017). 
In our population, the consumption of 100 g of seafood increased the 
urinary concentrations of AB by 109%. It is well-established that AB is 
the major As species present in fish (European Food Safety Authority, 
2009). This organoarsenical is considered non-toxic, because it is rapidly 
excreted without undergoing any change (European Food Safety Au-
thority, 2009). Additionally, we observed that fish consumption during 
pregnancy was positively associated with urinary DMA levels. The 
explanation for this finding could be related to some more complex 
forms of As, such as arsenosugars and arsenolipids, detected in fish, 
marine algae and filter feeders (European Food Safety Authority, 2009; 
Taylor et al., 2017b). It has been suggested that these As forms are 
biotransformed in the human body into species like DMA (Molin et al., 
2012). In relation to the inorganic forms, iAs levels in fish and shellfish 
are thought to be low (European Food Safety Authority, 2014). Never-
theless, Spain has recently been reported as one of the European coun-
tries with the highest iAs intake through fish and seafood, especially 
among Mediterranean high consumers of molluscs (Ferrante et al., 
2019). Indeed, in our population, the consumption of 100 g of shellfish 
and molluscs was associated with an increase of 146% in urinary iAs 
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concentrations (CI95%: 38,341%). This increase was stronger than the 
association with rice consumption (26%, CI95%: 4,52%). 
Other food groups associated with the As species concentrations in 
our study were meat, legumes and vegetables. We observed that the 
daily intake of 100 g of meat was associated with a 16% reduction in 
MMA, and when the different categories of meat were studied, only red 
meat remained statistically significant. This finding seems to be in 
agreement with the Strong Heart Family Study, where the authors 
observed a negative relationship between red meat consumption and 
ΣAs (Nigra et al., 2019). These associations may reflect nutrients found 
in red meat that have been associated with As metabolism, such as Zn 
and Fe, and certain OCM nutrients, such as vitamin B12, choline and 
methionine (Kurzius-Spencer et al., 2017). 
The consumption of legumes was also negatively associated with TAs 
and AB concentrations, but positively related to iAs concentrations, with 
an effect size similar to that of rice consumption (an increase of 30% in 
the iAs levels per daily intake of 100 g of any of these foods). Overall, 
legumes showed low levels of TAs (European Food Safety Authority, 
2009), but the content of iAs was relatively high (66% of the TAs was 
iAs) (Agencia Catalana de Seguretat Alimentaria, 2017). In addition, 
Spain is the third highest consumer of legumes in the European Union 
(Food and Agriculture Organization of the United Nations, 2017). In our 
population, vegetable consumption was directly associated with ΣAs, 
DMA and MMA levels, each metabolite increasing by 5% per 100 g of 
vegetable intake. The iAs concentrations seem to vary with the type of 
vegetable. For example, the iAs levels measured in vegetables marketed 
in Valencia ranged between 0.0001 mg/kg of fresh mass in tomatoes to 
0.02 mg/kg in aubergines, courgette and cucumber (Marín et al., 2018). 
In addition, the relatively high frequency of consumption of this type of 
food in our population (around 200 g per day) could explain the positive 
relationship with some As species. 
4.3. Factors associated with As exposure: other factors 
In our study, we have found differences in all As species concentra-
tions, except for ΣAs, according to the study area. In Valencia, urinary 
MMA and iAs concentrations were higher than in Gipuzkoa. The dietary 
pattern in each area seems to be different. For example, women from 
Valencia consumed more rice (mean [SD] = 61 [32] grams per day) than 
those from Gipuzkoa (mean [SD] = 33[20] grams per day) (Table S4). 
Women from Valencia also consumed more shellfish and molluscs than 
women from Gipuzkoa. Ferrante (2019) reported that molluscs sampled 
on the Mediterranean coasts presented higher iAs concentrations (0.50 
mg/kg wet weight, w.w.) than those sampled on the Atlantic coast (0.01 
mg/kg w.w). These differences in the dietary habits could explain the 
geographical variability in iAs exposure observed in this study. 
In our study, women born in Latin America presented lower con-
centrations of AB. This observation could be related to their lower 
consumption of fish in comparison to Spanish women (mean [SD] = 384 
[210] grams per week vs. 570 [251] grams per week]). In fact, when the 
model was adjusted for the total fish intake, the coefficients for the 
women’s place of origin were attenuated. Similarly, results from the US 
National Health and Nutrition Examination Survey showed slightly 
lower levels of urinary AB in a Mexican American population, compared 
to the Non-Hispanic white and the black population (Caldwell et al., 
2009). 
4.4. Evaluation of As methylation 
The process underlying iAs metabolism is still not fully understood. 
Nowadays, the proposed iAs metabolism pathways include an enzymatic 
reduction (from pentavalent to trivalent forms) and a methylation pro-
cess, giving rise to MMA and DMA forms, in a first and second step, 
respectively (Cullen, 2014). The MMA form is considered more toxic 
than DMA and so this methylation process is thought to be a detoxifi-
cation mechanism, although it has been shown that intermediate 
compounds can be highly toxic (Vahter, 2002). The relative proportion 
of each urinary metabolite (iAs, MMA and DMA) over the sum of those 
species has been used to reflect the individual iAs methylation efficiency 
(Agency for Toxic Substances and Disease Registry, 2007). However, 
this method seems to be inappropriate for populations with low expo-
sure to iAs through water and with high fish and seafood consumption, 
such as Spain (Navas-Acien et al., 2011), because, as a metabolite from 
the As species of fish, DMA could be overestimating the iAs exposure. In 
order to solve this problem, some strategies have been proposed, such as 
the residual-based method developed by Jones et al. (2016). In the 
present study, we have applied this approach to obtain a more accurate 
assessment of iAs metabolism. In fact, we have observed differences 
between the calibrated and non-calibrated percentages. 
Several studies have used the percentages method to assess the iAs 
metabolism efficiency. However, a limitation of this approach is that the 
three percentages are highly correlated with each other, which hinders 
the interpretation of the results. In order to minimize this problem, some 
authors have proposed the use of a principal component analysis by 
transforming the three interrelated variables into two independent 
measures of As metabolism phenotypes (Balakrishnan et al., 2016; 
Gribble et al., 2015; Jansen et al., 2016; Spratlen et al., 2017). The first 
component, PC1, has been suggested to show the capacity of producing 
DMA (higher methylation efficiency) and explains the highest percent-
age of the original variance. That is, PC1 seems to represent the second 
step of metabolism, or the overall metabolism efficiency. In our study, 
PC1 agreed with these previous studies, indicating an inverse relation 
between %iAs and %DMA. Regarding the pattern for PC2, it has been 
interpreted as the first step of metabolism, or the capacity to transform 
iAs into MMA. In our results, PC2 showed a negative correlation be-
tween the %MMA and %iAs, regardless of %DMA. Until now, there has 
been no consensus on which is the most accurate approach to evaluate 
the efficiency of As methylation, bearing in mind that As metabolism is 
still under study and that the metabolites could also reflect dietary 
sources. 
For this reason, interpretation of the results is complex and they 
should be taken with caution. 
4.5. Factors associated with iAs methylation efficiency 
One factor related to As methylation efficiency is the women’s place 
of origin. Latin-American women presented higher methylation of iAs, 
represented by a higher %DMA and lower %MMA. This association 
remained even after adjusting for diet and other variables that can affect 
As exposure. This result is consistent with those of other studies, which 
have shown differences in metabolism depending on the ethnicity of the 
participants. A study carried out in USA showed a slightly higher 
methylation efficiency among Hispanic people than non-Hispanic white, 
African American and Chinese American people (Balakrishnan et al., 
2018). In the same way, a recent study has reported a more efficient 
methylation pattern (denoted by higher %DMA and lower %iAs) in 
US-born and foreign-born pregnant Hispanic women, compared with 
their non-Hispanic counterparts (Farzan et al., 2020). Other studies 
found that ethnicity was the strongest factor associated with As meta-
bolism, even if the models were adjusted for water exposure (De Loma 
et al., 2019; Hopenhayn-Rich et al., 1996). It has been observed that 
some South American populations exposed to high levels of iAs for 
generations have a higher iAs methylation efficiency (higher DMA 
excretion) that has been acquired by a higher presence of the protective 
genetic variants in the Arsenic [+3 oxidation state] methyltransferase 
(AS3MT) gene, considered to be the major contributor to As methylation 
efficiency (Schlebusch et al., 2015; Vahter et al., 1995). 
Our results indicated a positive relationship between the women’s 
BMI and methylation efficiency, i.e. women with higher BMI present a 
decrease in %iAs and %MMA and an increase in %DMA. This pattern has 
also been observed in previous studies (Bommarito et al., 2019; Shen 
et al., 2016). The mechanism underlying the relationship between As 
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methylation and BMI is still unclear; however, some studies postulate 
that worse kidney function or the intake of certain proteins, both asso-
ciated with an increasing BMI, could be associated with an increased 
DMA excretion (Duan et al., 2019; Peters et al., 2015; Vahter, 2007). 
The gestational age at sampling was inversely related to the %MMA. 
This result is consistent with the findings of previous studies, which 
show an increase in methylation efficiency throughout pregnancy, 
denoted by higher %DMA and lower %MMA and iAs (Gardner et al., 
2011; Hopenhayn et al., 2003). It has been suggested that As metabolism 
is elevated during the course of pregnancy due to a more efficient 
maternal one-carbon metabolism that increases the endogenous syn-
thesis of the methyl-donor choline so as to be able to supply the high 
fetal demand for correct development (Vahter, 2009). Nevertheless, in 
our study, gestational age was only related to %MMA, but it was not 
associated with an increase in %DMA. Unfortunately, in our study we 
measured As metabolite concentrations in one-spot urine samples dur-
ing pregnancy, which prevents us from evaluating whether this 
decreasing trend in %MMA is due to an improvement in As methylation 
or a change in the maternal diet. 
In our study, smoker women presented a lower iAs methylation ef-
ficiency by showing a decrease in PC1 (understood as the overall 
metabolism efficiency). This result is in agreement with previous studies 
(Shen et al., 2016; Tseng, 2008). Tobacco consumption has been 
observed to decrease concentrations of one-carbon nutrients, such as 
vitamin B12 and folate, which could be affecting the As methylation 
efficiency (Mouhamed et al., 2011). Another possible explanation could 
be related to the presence of other metals in the tobacco, such as Cd, 
which could modify As metabolism. This metal seems to bind to reduced 
glutathione (GSH) (Zalups and Ahmad, 2003), which is an antioxidant 
involved in the reduction from trivalent to pentavalent As species. In 
fact, in our population, urinary Cd concentrations were directly associ-
ated with an increase in %MMA. 
We also observed an association between the estimation of Fe intake 
and the As metabolism efficiency, specifically with decreasing PC1. In 
experimental studies, this element seems to diminish the bioaccessibility 
of As in the gut (Yu et al., 2016). Nevertheless, in a randomized 
controlled trial study conducted with Mexican children, supplementa-
tion with Fe had no impact on the As metabolism (Kordas et al., 2017). 
In this same study, Zn supplementation was not related to better As 
metabolism. These results seem to be in disagreement with those found 
in our study, where estimated Zn consumption was positively associated 
with the %DMA, although the coefficients did not reach statistical sig-
nificance. Similarly to our findings, in an observational study conducted 
on Mexican women, the estimated Zn intake was related to a decrease in 
%MMA and %iAs, and an increase in %DMA (López-Carrillo et al., 
2016). Zn is a necessary cofactor of betaine homocysteine methyl-
transferase (BHMT; EC 2.1.1.5). This enzyme uses betaine as a methyl 
donor and Zn as a cofactor for the remethylation of homocysteine to 
methionine (Millian and Garrow, 1998). 
Finally, we did not observe any statistically significant association 
between As methylation efficiency and the estimated intake of OCM 
nutrients. Previous studies have observed an influence of some of these 
nutrients on iAs methylation, such as folate and vitamins B6 and B12, 
which are involved in the synthesis of S-adenosylmethionine (SAM), the 
main donor of the methyl group in iAs methylation (Bozack et al., 2019; 
Gamble et al., 2005; Howe et al., 2017b; Kurzius-Spencer et al., 2017). 
However, the results from studies conducted on populations of pregnant 
women have been heterogeneous; thus, in a Mexican cohort, no asso-
ciation was observed between levels of vitamin B12 in serum and the 
percentages of the urinary arsenic metabolites (Laine et al., 2018). A 
study of pregnant women in Bangladesh showed a marginal negative 
association with plasma folate and %iAs, but no association with 
vitamin B12 was found (Li et al., 2008). Additionally, plasma folate was 
inversely associated with the urinary percentage of As+5 before delivery 
(Hall et al., 2007). However, in that same cohort, an increase in 
methylation efficiency throughout the pregnancy was observed 
regardless of the women’s folate and vitamin B12 status (Gardner et al., 
2011). It has been suggested that As metabolism is more efficient during 
pregnancy due to an increase in the endogenous synthesis of the 
methyl-donor choline, in order to meet the high fetal demand (Vahter, 
2009). This specific process during pregnancy may lead to certain co-
factors or methyl-donors, such as folate, having a marginal influence on 
As metabolism (Gardner et al., 2011). Moreover, it is possible that in 
well-nourished populations it is more difficult to observe the influence 
of the one-carbon nutrients than in populations with nutritional de-
ficiencies. In fact, Howe (2014) revealed a positive association between 
blood SAM and %MMA in folate and cobalamin-deficient participants, 
but this association was not found in the micronutrient-sufficient group. 
In our populations, only 22%, 2% and 16% of women had estimated 
levels of vitamins B6, B12 and folate intake, respectively, below the 
recommendations (European Food Safety Authority, 2019), and only 4% 
of the participants did not take folic acid supplements at the first 
trimester of pregnancy. 
This study has several limitations: 1) around 30% of the recruited 
participants were not included in this study, and participants could have 
a more privileged socioeconomic profile than non-participants. This fact 
could be related to dietary habits that can lead to differences in exposure 
to different forms of As; 2) another limitation in our study could be 
related to the assessment of As exposure at only one time point during 
pregnancy. This could reflect only recent As exposure and it might not be 
representative of the period of pregnancy as a whole; 3) the present 
study lacks information on some important nutrients involved in OCM 
and related to As metabolism, such as choline and betaine, and thus the 
influence of these variables could not be tested; 4) finally, we used 
creatinine concentrations to control for urinary dilution. Creatinine 
concentrations seem to be associated with As metabolism. To control for 
this effect, we used the approach proposed by Barr et al. (2005), which 
involves including the creatinine concentrations in the multivariate 
models as a separate independent variable. Nevertheless, due to the 
complexity of the interrelations between As metabolism, micronutrients 
and creatinine, the interpretation of the factors associated with As 
metabolism should be taken with caution. 
The major strength of the present study is the analysis of As specia-
tion in a considerably large sample size. In fact, as far as we know, this is 
the largest European study describing As species concentrations and 
methylation efficiency in pregnant women. Another advantage is the 
analysis of As methylation efficiency through two approaches: using the 
relative percentages of each As metabolite and, in order to minimize the 
high correlation between the three percentages, using a principal 
component analysis. This allows comparability with previous studies 
that have used either of these two methods to evaluate the efficiency of 
arsenic metabolism. 
5. Conclusions 
The concentrations of the urinary As species in our study were 
slightly higher compared to other populations with low environmental 
exposure to As through water intake. Rice and seafood consumption, 
especially shellfish and molluscs, were the major contributors to the 
urinary concentrations of As species during pregnancy. Vegetables, le-
gumes, eggs and other cereals contributed to the concentrations of 
different species of As during pregnancy. In the present study, the intake 
of nutrients and vitamins seemed to be weakly related to methylation 
efficiency. The consumption of tobacco in pregnancy, the women’s place 
of origin and their body mass index were also associated with the 
methylation efficiency. Further birth cohort studies in low exposure 
areas are necessary to improve knowledge about prenatal arsenic 
exposure, especially of its inorganic forms, and its potential health 
impact during childhood. This information could be used to propose new 
strategies in public health. 
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Kordas, K., Roy, A., López, P., García-Vargas, G., Cebrián, M.E., Vera-Aguilar, E., 
Rosado, J.L., 2017. Iron and zinc supplementation does not impact urinary arsenic 
excretion in Mexican school children. J. Pediatr. 185, 205–210. https://doi.org/ 
10.1016/j.jpeds.2017.02.040. 
Kurzius-Spencer, M., Thomson, C.A., Hartz, V., Hsu, C., Burgess, J.L., Kay, M., 
Rourke, O., Harris, R.B., 2017. Nutrients in one-carbon metabolism and urinary 
arsenic methylation in the national health and nutrition examination Survey 
(NHANES) 2003–2004. Sci. Total Environ. 607– 608, 381–390. https://doi.org/ 
10.1016/j.scitotenv.2017.07.019. 
Laine, J.E., Bailey, K.A., Rubio-andrade, M., Olshan, A.F., Smeester, L., 2015. Maternal 
arsenic exposure , arsenic methylation efficiency , and birth outcomes in the 
biomarkers of exposure to ARsenic ( BEAR ) pregnancy cohort in Mexico. Child. 
Heal. 123, 186–192. 
Laine, J.E., Ilievski, V., Richardson, D.B., Herring, A.H., Stýblo, M., Rubio-Andrade, M., 
Garcia-Vargas, G., Gamble, M.V., Fry, R.C., 2018. Maternal one carbon metabolism 
and arsenic methylation in a pregnancy cohort in Mexico. J. Expo. Sci. Environ. 
Epidemiol. 28, 505–514. https://doi.org/10.1038/s41370-018-0041-1. 
Li, L., Ekström, E.C., Goessler, W., Lönnerdal, B., Nermell, B., Yunus, M., Rahman, A., El 
Arifeen, S., Persson, L.Å., Vahter, M., 2008. Nutritional status has marginal influence 
on the metabolism of inorganic arsenic in pregnant Bangladeshi women. Environ. 
Health Perspect. 116, 315–321. https://doi.org/10.1289/ehp.10639. 
Litter, M.I., Armienta, M.A., Villanueva Estrada, R.E., Villaamil Lepori, E.C., Olmos, V., 
2020. Arsenic in Latin-America: Part I. In: Srivastava, S. (Ed.), Arsenic in Drinking 
Water and Food. Springer Nature Singapore, Singapore.  
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